tradingkey.logo

Stereotaxis Inc

STXS
2.030USD
+0.050+2.53%
Handelsschluss 02/06, 16:00ETKurse um 15 Minuten verzögert
184.90MMarktkapitalisierung
VerlustKGV TTM

Stereotaxis Inc

2.030
+0.050+2.53%

mehr Informationen über Stereotaxis Inc Unternehmen

Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory. Its proprietary robotic technology, Robotic Magnetic Navigation (RMN), fundamentally transforms endovascular interventions using precise computer-controlled magnetic fields to directly control the tip of flexible interventional catheters or devices. The Company’s primary products include the Genesis RMN System, the Odyssey Solution, and other related devices. Through its strategic relationships with fluoroscopy system manufacturers, providers of catheters and electrophysiology mapping systems, and other parties, the Company offers its customers x-ray systems and other accessory devices. The Genesis RMN System is designed to enable physicians to complete more complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites.

Stereotaxis Inc Informationen

BörsenkürzelSTXS
Name des UnternehmensStereotaxis Inc
IPO-datumAug 12, 2004
CEOFischel (David Leo)
Anzahl der mitarbeiter139
WertpapierartOrdinary Share
GeschäftsjahresendeAug 12
Addresse710 N Tucker Blvd
StadtST. LOUIS
BörseNASDAQ OMX – NASDAQ Basic Amex
LandUnited States of America
Postleitzahl63101
Telefon13146786100
Websitehttps://www.stereotaxis.com/
BörsenkürzelSTXS
IPO-datumAug 12, 2004
CEOFischel (David Leo)

Führungskräfte von Stereotaxis Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Nathan Fischel, M.D.
Dr. Nathan Fischel, M.D.
Director
Director
13.97M
+46948.00%
Mr. David W. Benfer
Mr. David W. Benfer
Lead Independent Director
Lead Independent Director
553.92K
+46948.00%
Dr. Myriam J. Curet, M.D.
Dr. Myriam J. Curet, M.D.
Independent Director
Independent Director
392.06K
+46948.00%
Mr. David Leo Fischel
Mr. David Leo Fischel
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
200.00K
+60000.00%
Mr. Ross B. Levin
Mr. Ross B. Levin
Independent Director
Independent Director
185.59K
+46948.00%
Mr. Nachum (Homi) Shamir
Mr. Nachum (Homi) Shamir
Director
Director
136.22K
+46948.00%
Dr. Arun Swarup Menawat, Ph.D.
Dr. Arun Swarup Menawat, Ph.D.
Independent Director
Independent Director
--
--
Ms. Kimberly R. Peery
Ms. Kimberly R. Peery
Chief Financial Officer
Chief Financial Officer
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Nathan Fischel, M.D.
Dr. Nathan Fischel, M.D.
Director
Director
13.97M
+46948.00%
Mr. David W. Benfer
Mr. David W. Benfer
Lead Independent Director
Lead Independent Director
553.92K
+46948.00%
Dr. Myriam J. Curet, M.D.
Dr. Myriam J. Curet, M.D.
Independent Director
Independent Director
392.06K
+46948.00%
Mr. David Leo Fischel
Mr. David Leo Fischel
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
200.00K
+60000.00%
Mr. Ross B. Levin
Mr. Ross B. Levin
Independent Director
Independent Director
185.59K
+46948.00%
Mr. Nachum (Homi) Shamir
Mr. Nachum (Homi) Shamir
Director
Director
136.22K
+46948.00%

Umsatzaufteilung

Währung: USDAktualisiert: Tue, Jan 6
Währung: USDAktualisiert: Tue, Jan 6
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Nach RegionUSD
Name
Umsatz
Anteil
International
13.49M
50.12%
United States
13.43M
49.88%
Nach Geschäftsbereich
Nach Region
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.

Aktionärsstatistik

Aktualisiert: Fri, Dec 5
Aktualisiert: Fri, Dec 5
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Fischel (Nathan)
14.96%
Dafna Capital Management, LLC
14.66%
Kiani (Joe E)
9.49%
Lagoda Investment Management, L.P.
5.04%
The Vanguard Group, Inc.
3.96%
Andere
51.88%
Aktionäre
Aktionäre
Anteil
Fischel (Nathan)
14.96%
Dafna Capital Management, LLC
14.66%
Kiani (Joe E)
9.49%
Lagoda Investment Management, L.P.
5.04%
The Vanguard Group, Inc.
3.96%
Andere
51.88%
Aktionärstypen
Aktionäre
Anteil
Individual Investor
28.86%
Hedge Fund
19.47%
Investment Advisor
17.46%
Investment Advisor/Hedge Fund
9.42%
Corporation
3.30%
Research Firm
0.62%
Bank and Trust
0.07%
Venture Capital
0.04%
Pension Fund
0.01%
Andere
20.75%

Institutionelle Beteiligung

Aktualisiert: Mon, Jan 5
Aktualisiert: Mon, Jan 5
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q4
184
43.86M
46.99%
-1.92M
2025Q3
175
41.68M
45.77%
-4.01M
2025Q2
184
70.71M
77.86%
+13.38M
2025Q1
192
70.55M
82.04%
+9.72M
2024Q4
185
55.40M
64.94%
-4.27M
2024Q3
178
54.77M
64.71%
-4.91M
2024Q2
173
55.07M
66.24%
-4.36M
2024Q1
185
55.40M
67.15%
-4.49M
2023Q4
184
51.49M
64.77%
-9.27M
2023Q3
189
52.12M
65.60%
-9.17M
Mehr Anzeigen

Aktionärsaktivitäten

Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Fischel (Nathan)
13.92M
15.35%
+43.67K
+0.31%
Jul 01, 2025
Dafna Capital Management, LLC
13.68M
14.66%
--
--
Sep 30, 2025
Kiani (Joe E)
8.86M
9.49%
+427.40K
+5.07%
Mar 17, 2025
Lagoda Investment Management, L.P.
4.71M
5.04%
+19.50K
+0.42%
Sep 30, 2025
The Vanguard Group, Inc.
3.44M
3.69%
+138.48K
+4.19%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
3.68M
3.94%
+76.90K
+2.13%
Sep 30, 2025
2012 Revocable Trust of Andrew Redleaf
3.08M
3.3%
--
--
Mar 17, 2025
Arbiter Partners Capital Management, LLC
2.85M
3.06%
--
--
Sep 30, 2025
Isaac (Paul J)
2.06M
2.21%
+10.00K
+0.49%
Nov 17, 2025
Essex Investment Management Company, LLC
1.60M
1.71%
+53.36K
+3.45%
Sep 30, 2025
Mehr Anzeigen

Verbundene ETFs

Aktualisiert: Sat, Dec 6
Aktualisiert: Sat, Dec 6
Name
Anteil
iShares Micro-Cap ETF
0.03%
Global X Russell 2000 ETF
0.01%
Proshares Ultra Russell 2000
0.01%
ProShares UltraPro Russell2000
0.01%
ProShares Hedge Replication ETF
0.01%
iShares Russell 2000 Growth ETF
0.01%
iShares Russell 2000 Value ETF
0%
iShares Russell 2000 ETF
0%
iShares Micro-Cap ETF
Anteil0.03%
Global X Russell 2000 ETF
Anteil0.01%
Proshares Ultra Russell 2000
Anteil0.01%
ProShares UltraPro Russell2000
Anteil0.01%
ProShares Hedge Replication ETF
Anteil0.01%
iShares Russell 2000 Growth ETF
Anteil0.01%
iShares Russell 2000 Value ETF
Anteil0%
iShares Russell 2000 ETF
Anteil0%

Dividende

In den vergangenen 5 Jahren wurden insgesamt 0.00 USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten

Aktien-Split

Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
KeyAI